NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is P73398952. A total of 2 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 100 | -98.1% | 0.00% | – |
Q1 2022 | $6,000 | +100.0% | 5,300 | +76.7% | 0.00% | – |
Q4 2021 | $3,000 | -75.0% | 3,000 | -63.0% | 0.00% | – |
Q3 2021 | $12,000 | 0.0% | 8,100 | 0.0% | 0.00% | – |
Q2 2021 | $12,000 | -7.7% | 8,100 | +13178.7% | 0.00% | – |
Q1 2021 | $13,000 | -51.9% | 61 | -44.5% | 0.00% | – |
Q4 2020 | $27,000 | +3.8% | 110 | +2.8% | 0.00% | – |
Q3 2020 | $26,000 | +136.4% | 107 | +245.2% | 0.00% | – |
Q2 2020 | $11,000 | -35.3% | 31 | -57.5% | 0.00% | – |
Q1 2020 | $17,000 | +240.0% | 73 | +180.8% | 0.00% | – |
Q4 2019 | $5,000 | +400.0% | 26 | +333.3% | 0.00% | – |
Q3 2019 | $1,000 | – | 6 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 6 | -87.8% | 0.00% | – |
Q1 2019 | $9,000 | -84.7% | 49 | -89.2% | 0.00% | – |
Q4 2018 | $59,000 | -88.7% | 453 | -78.7% | 0.00% | -100.0% |
Q3 2018 | $522,000 | -27.7% | 2,125 | -1.1% | 0.00% | -33.3% |
Q2 2018 | $722,000 | +1064.5% | 2,149 | +78.3% | 0.00% | 0.0% |
Q1 2018 | $62,000 | +31.9% | 1,205 | -30.3% | 0.00% | +50.0% |
Q4 2017 | $47,000 | -30.9% | 1,730 | -5.4% | 0.00% | -33.3% |
Q3 2017 | $68,000 | +3.0% | 1,829 | +41.7% | 0.00% | 0.0% |
Q2 2017 | $66,000 | +65.0% | 1,291 | -20.7% | 0.00% | +50.0% |
Q1 2017 | $40,000 | -31.0% | 1,628 | +78.1% | 0.00% | -33.3% |
Q4 2016 | $58,000 | +5700.0% | 914 | +927.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 89 | +8800.0% | 0.00% | – |
Q2 2016 | $0 | – | 1 | -94.4% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 18 | -89.2% | 0.00% | -100.0% |
Q4 2015 | $9,000 | – | 166 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|